Nocturia Market- by Types (Mixed Nocturia, Bladder storage problems, Nocturnal polyuria), by Causes (Urological infection, Tumor of the bladder, Diuretic medications, Regular alcohol or coffee, Liver infection, Diabetes, Pregnancy, Others)- Global Industry Perspective Comprehensive Analysis and Forecast, 2020 - 2026

Published Date: 08-Dec-2020 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-1528 Status : Published

According to the report, global demand for Nocturia market was valued at approximately USD 2.8 billion in 2019, and is expected to generate revenue of around USD 4.8 billion by end of 2026, growing at a CAGR of around 7.9 % between 2020 and 2026.

Description

According to the report, global demand for Nocturia market was valued at approximately USD 2.8 billion in 2019, and is expected to generate revenue of around USD 4.8 billion by end of 2026, growing at a CAGR of around 7.9 % between 2020 and 2026.

Global Nocturia Market: Overview

Experiencing frequent urge of urination during the night after sleeping is a medical condition that is termed as nocturia or nocturnal polyuria. This happens among the aged patients and sleep deficiency can often lead to nocturia. The women that are between 18 to 49 years have more chances of having nocturia than men, the percentage reverses after the age of 60. Other reasons that cause nocturia are depression, mental stress, low level of physical activities, and congestive heart failure.

Global Nocturia Market: Segmentation

The global nocturia market is segmented into its types, causes, and regions. On the basis of types, the market is segregated into mixed nocturia, bladder storage problems, and nocturnal polyuria. Based on the causes, the market is categorized into urological infection, a tumor of the bladder, diuretic medications, regular alcohol or coffee, liver infection, diabetes, pregnancy, and others. The geographical segmentation of the global nocturia market includes North America, Asia Pacific, Europe, and Rest of the World.

Global Nocturia Market: Growth Factors

For the proper cure of nocturia, diagnosis to cardiac symptoms, identification of neurological disorders, hypertension, and intake of medicines such as cardiac glycosides should be appropriate, thus awareness about the condition has increased. A thorough examination of the patients should be done to diagnose for sleep apnea, lower limb edema, obesity, and pelvic analysis. The diagnostics segment of the nocturia market will maintain a consistent demand as the population of the aged people is increasing across the global. According to the study conducted by the National Institute of Aging around 1.6 billion of the population will be aged over 65 by 2050. Surgical intervention with respect to transurethral prostatectomy and pelvic organ prolapse repair are the final approaches for surgeons and physicians. In past couple of years, nocturia has gained a lot of attention owing to its increased cases has prompted researches and manufacturers to make investments thereby improving quality sleep and on the whole increasing the life rating. Some of the drugs that are pipelined include desmopressin acetate, fedovapagon, afacifenacin, ASP-7035, Paxerol, lidocaine, among others.

Global Nocturia Market: Regional Analysis

Due to the sophisticated healthcare infrastructure in the countries such as US and Canada the North American region has emerged as the most lucrative region in the global market for nocturia. Europe too is experiencing a positive approach owing to the feasible support, rising aging population, and sponsorship from government agencies and private companies. Asia-Pacific and other regional markets are also growing in the nocturia market owing to the rise in the research activities thus contributing significantly in the global nocturia market. For the new market players and the existing ones, these regions provide a pool of opportunities to grow and explore in this field owing to rise in disposable income, developments in healthcare infrastructure, and increasing incidences of bladder cancer and diabetes conditions.

Global Nocturia Market: Competitive Players

Some of the key market players that are involved in the nocturia market include Allergan, Inc., Vantia Therapeutics, Astellas Pharma Inc., Urigen Pharmaceuticals, Inc., and Dainippon Sumitomo Pharma Co., Ltd.

The report segments the Global Nocturia market as follows:

Global Nocturia Market: Types Segment Analysis

  • Mixed Nocturia
  • Bladder storage problems
  • Nocturnal polyuria

Global Nocturia Market: Causes Segment Analysis

  • Urological infection
  • Tumor of the bladder
  • Diuretic medications
  • Regular alcohol or coffee
  • Liver infection
  • Diabetes
  • Pregnancy
  • Others

Global Nocturia Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Nocturia Market, 2016–2025 (USD Billion)
    • 2.2. Nocturia Market: Snapshot
  • Chapter 3. Nocturia Market – Industry Analysis
    • 3.1. Nocturia Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. The increasing access to manufacturing infrastructure
      • 3.2.2. Rising advancements in the drug delivery systems
    • 3.3. Restraints
      • 3.3.1. High operational costs
    • 3.4. Opportunities
      • 3.4.1. Rising focus of the key players on research activities and the development of new products
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Types
      • 3.6.2. Market attractiveness analysis By Causes
      • 3.6.3. Market attractiveness analysis by Region
  • Chapter 4. Nocturia Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Nocturia Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Types launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Nocturia Market –Types Analysis
    • 5.1. Global Nocturia Market overview: By Types
      • 5.1.1. Global Nocturia Market share, By Types,2018 and 2025
    • 5.2. Mixed Nocturia
      • 5.2.1. Global Nocturia Market by Mixed Nocturia, 2016–2025 (USD Billion)
    • 5.3. Bladder storage problems
      • 5.3.1. Global Nocturia Market by Bladder storage problems, 2016–2025 (USD Billion)
    • 5.4. Nocturnal pulyuria
      • 5.4.1. Global Nocturia Market by Nocturnal pulyuria, 2016–2025 (USD Billion)
  • Chapter 6. Global Nocturia Market –Causes Analysis
    • 6.1. Global Nocturia Market overview: By Causes
      • 6.1.1. Global Nocturia Market share, By Causes, 2018 and 2025
    • 6.2. Urulogical infection
      • 6.2.1. Global Nocturia Market by Urulogical infection, 2016–2025 (USD Billion)
    • 6.3. Tumor of the bladder
      • 6.3.1. Global Nocturia Market by Tumor of the bladder, 2016–2025 (USD Billion)
    • 6.4. Diuretic medications
      • 6.4.1. Global Nocturia Market by Diuretic medications, 2016–2025 (USD Billion)
    • 6.5. Regular alcohul or coffee
      • 6.5.1. Global Nocturia Market by Regular alcohul or coffee, 2016–2025 (USD Billion)
    • 6.6. Liver infection
      • 6.6.1. Global Nocturia Market by Liver infection, 2016–2025 (USD Billion)
    • 6.7. Diabetes
      • 6.7.1. Global Nocturia Market by Diabetes, 2016–2025 (USD Billion)
    • 6.8. Pregnancy
      • 6.8.1. Global Nocturia Market by Pregnancy, 2016–2025 (USD Billion)
    • 6.9. Others
      • 6.9.1. Global Nocturia Market by Others, 2016–2025 (USD Billion)
  • Chapter 7. Global Nocturia Market - Regional Analysis
    • 7.1. Global Nocturia Market overview: by Region
      • 7.1.1. Global Nocturia Market share, by Region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Nocturia Market, 2016–2025 (USD Billion)
      • 7.2.2. North America Nocturia Market revenue, By Types,2016–2025 (USD Billion)
      • 7.2.3. North America Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.2.4.2. U.S. Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.2.5.2. Rest of North America Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Nocturia Market, 2016–2025 (USD Billion)
      • 7.3.2. Europe Nocturia Market revenue, By Types,2016–2025 (USD Billion)
      • 7.3.3. Europe Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.3.4. UK
        • 7.3.4.1. U.K. Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.3.4.2. U.K. Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.3.5.2. France Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.3.6. Germany
        • 7.3.6.1. Germany Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.3.6.2. Germany Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.3.7.2. Rest of Europe Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Nocturia Market, 2016–2025 (USD Billion)
      • 7.4.2. Asia Pacific Nocturia Market revenue, By Types,2016–2025 (USD Billion)
      • 7.4.3. Asia Pacific Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.4.4. China
        • 7.4.4.1. China Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.4.4.2. China Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.4.5.2. Japan Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.4.6. India
        • 7.4.6.1. India Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.4.6.2. India Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.4.7.2. Rest of Asia Pacific Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Nocturia Market, 2016–2025 (USD Billion)
      • 7.5.2. Latin America Nocturia Market revenue, By Types,2016–2025 (USD Billion)
      • 7.5.3. Latin America Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.5.4.2. Brazil Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America Nocturia Market revenue, By Types,2016–2025 (USD Billion)
        • 7.5.5.2. Rest of Latin America Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Nocturia Market, 2016–2025 (USD Billion)
      • 7.6.2. The Middle East and Africa Nocturia Market revenue, By Types,2016–2025 (USD Billion)
      • 7.6.3. The Middle East and Africa Nocturia Market revenue, By Causes, 2016–2025 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Allergan, Inc
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Types Portfulio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Vantia Therapeutics
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Types Portfulio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Astellas Pharma Inc
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Types Portfulio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Urigen Pharmaceuticals
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Types Portfulio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Dainippon Sumitomo Pharma Co., Ltd.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Types Portfulio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development

Methodology

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com